Logo
x

Search

Subscribe Now

initiate

BioNTech Plans to Initiate the Clinical Study of Malaria and Tuberculosis Vaccines in 2022

BioNTech Plans to Initiate the Clinical Study of Malaria and Tuberculosis Vaccines in 2022

  • July 27, 2021
Alphamab and Pfizer Initiate P-II Trial Evaluating KN046 + Inlyta (axitinib) as a 1L Treatment of Non-Small Cell Lung Cancer

Alphamab and Pfizer Initiate P-II Trial Evaluating KN046 + Inlyta (axitinib) as a 1L Treatment of Non-Small Cell Lung Cancer

  • April 30, 2021
Novo Nordisk to Initiate P-IIIa Study for Oral Semaglutide to Treat Obesity

Novo Nordisk to Initiate P-IIIa Study for Oral Semaglutide to Treat Obesity

  • April 22, 2021
Claritas Collaborates with CMAX to Initiate P-I Study of R-107 for Pulmonary Arterial Hypertension

Claritas Collaborates with CMAX to Initiate P-I Study of R-107 for Pulmonary Arterial Hypertension

  • April 22, 2021
FibroGen Initiates P-III LELANTOS-2 Study of Pamrevlumab for Duchenne Muscular Dystrophy

FibroGen Initiates P-III LELANTOS-2 Study of Pamrevlumab for Duchenne Muscular Dystrophy

  • March 17, 2021
Sanofi and Translate Bio Initiate P-I/II Study of MRT5500 Against COVID-19

Sanofi and Translate Bio Initiate P-I/II Study of MRT5500 Against COVID-19

  • March 12, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.